Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GPN vs GSK✓SelectedUSD · GSKGPN vs GSK performance historyLatest closeAs of+0.35%11/18
Stock and ETF performance explorer

GPN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,415.9%
GSK return
+196.8%
Excess return
+2,219.1%
Maximum drawdown
-70.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%-1.3%+1.7%+0.9%
7D-14.6%-3.1%-11.4%-13.4%
30D+1.2%-0.9%+2.1%+1.5%
3M-5.0%-4.2%-0.8%-3.6%
6M+25.5%-1.6%+27.1%+25.5%
YTD+11.7%+2.6%+9.1%+9.1%
1Y+20.4%+6.2%+14.2%+15.8%
3Y-21.0%+55.0%-76.0%-37.8%
5Y-29.0%+42.8%-71.9%-43.2%
10Y+28.6%+102.1%-73.6%-12.7%
All+2,415.9%+196.8%+2,219.1%+1,267.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling